NPHP4
Nephrocystin-4
Also known as: KIAA0673, NPHP4_HUMAN, POC10, SLSN4
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O75161
- Gene
- NPHP4
- Ensembl
- ENSG00000131697
- Chromosome
- 1
- Canonical length
- 1426 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies,Vesicles,Cytosol
OverviewNCBI Gene
This gene encodes a protein involved in renal tubular development and function. This protein interacts with nephrocystin, and belongs to a multifunctional complex that is localized to actin- and microtubule-based structures. Mutations in this gene are associated with nephronophthisis type 4, a renal disease, and with Senior-Loken syndrome type 4, a combination of nephronophthisis and retinitis pigmentosa. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014]
Canonical amino-acid sequenceUniProt
1426 residues, UniProt reviewed canonical sequence.
>O75161|NPHP4
1 MNDWHRIFTQ NVLVPPHPQR ARQPWKESTA FQCVLKWLDG PVIRQGVLEV LSEVECHLRV
61 SFFDVTYRHF FGRTWKTTVK PTKRPPSRIV FNEPLYFHTS LNHPHIVAVV EVVAEGKKRD
121 GSLQTLSCGF GILRIFSNQP DSPISASQDK RLRLYHGTPR ALLHPLLQDP AEQNRHMTLI
181 ENCSLQYTLK PHPALEPAFH LLPENLLVSG LQQIPGLLPA HGESGDALRK PRLQKPITGH
241 LDDLFFTLYP SLEKFEEELL ELHVQDHFQE GCGPLDGGAL EILERRLRVG VHNGLGFVQR
301 PQVVVLVPEM DVALTRSASF SRKVVSSSKT SSGSQALVLR SRLRLPEMVG HPAFAVIFQL
361 EYVFSSPAGV DGNAASVTSL SNLACMHMVR WAVWNPLLEA DSGRVTLPLQ GGIQPNPSHC
421 LVYKVPSASM SSEEVKQVES GTLRFQFSLG SEEHLDAPTE PVSGPKVERR PSRKPPTSPS
481 SPPAPVPRVL AAPQNSPVGP GLSISQLAAS PRSPTQHCLA RPTSQLPHGS QASPAQAQEF
541 PLEAGISHLE ADLSQTSLVL ETSIAEQLQE LPFTPLHAPI VVGTQTRSSA GQPSRASMVL
601 LQSSGFPEIL DANKQPAEAV SATEPVTFNP QKEESDCLQS NEMVLQFLAF SRVAQDCRGT
661 SWPKTVYFTF QFYRFPPATT PRLQLVQLDE AGQPSSGALT HILVPVSRDG TFDAGSPGFQ
721 LRYMVGPGFL KPGERRCFAR YLAVQTLQID VWDGDSLLLI GSAAVQMKHL LRQGRPAVQA
781 SHELEVVATE YEQDNMVVSG DMLGFGRVKP IGVHSVVKGR LHLTLANVGH PCEQKVRGCS
841 TLPPSRSRVI SNDGASRFSG GSLLTTGSSR RKHVVQAQKL ADVDSELAAM LLTHARQGKG
901 PQDVSRESDA TRRRKLERMR SVRLQEAGGD LGRRGTSVLA QQSVRTQHLR DLQVIAAYRE
961 RTKAESIASL LSLAITTEHT LHATLGVAEF FEFVLKNPHN TQHTVTVEID NPELSVIVDS
1021 QEWRDFKGAA GLHTPVEEDM FHLRGSLAPQ LYLRPHETAH VPFKFQSFSA GQLAMVQASP
1081 GLSNEKGMDA VSPWKSSAVP TKHAKVLFRA SGGKPIAVLC LTVELQPHVV DQVFRFYHPE
1141 LSFLKKAIRL PPWHTFPGAP VGMLGEDPPV HVRCSDPNVI CETQNVGPGE PRDIFLKVAS
1201 GPSPEIKDFF VIIYSDRWLA TPTQTWQVYL HSLQRVDVSC VAGQLTRLSL VLRGTQTVRK
1261 VRAFTSHPQE LKTDPKGVFV LPPRGVQDLH VGVRPLRAGS RFVHLNLVDV DCHQLVASWL
1321 VCLCCRQPLI SKAFEIMLAA GEGKGVNKRI TYTNPYPSRR TFHLHSDHPE LLRFREDSFQ
1381 VGGGETYTIG LQFAPSQRVG EEEILIYIND HEDKNEEAFC VKVIYQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NPHP4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 7.6 nTPM
Expression across tissuesHPA
Tissue
- pituitary gland: 7.6 nTPM
- fallopian tube: 7.4 nTPM
- thyroid gland: 6.6 nTPM
- testis: 5.2 nTPM
- skin: 4.7 nTPM
- bone marrow: 3.5 nTPM
Single-cell type
- gonadotrophs: 100 nCPM
- lactotrophs: 91 nCPM
- ependymal cells: 85 nCPM
- corticotrophs: 84 nCPM
- somatotrophs: 79 nCPM
- choroid plexus epithelial cells: 74 nCPM
Immune cell
- basophil: 0.7 nTPM
- neutrophil: 0.2 nTPM
- classical monocyte: 0.1 nTPM
- MAIT T-cell: 0.1 nTPM
- NK-cell: 0.1 nTPM
- non-classical monocyte: 0.1 nTPM
Brain region
- hippocampal formation: 19 nTPM
- cerebral cortex: 18 nTPM
- choroid plexus: 18 nTPM
- amygdala: 14 nTPM
- basal ganglia: 14 nTPM
- white matter: 12 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NPHP4.
Disease | AllUniProt
Conditions NPHP4 is implicated in, by any mechanism.
- Nephronophthisis 4 (NPHP4) MIM:606966
- Senior-Loken syndrome 4 (SLSN4) MIM:606996
Disease | GeneticClinVar
159 pathogenic / likely-pathogenic of 1,955 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Nephronophthisis
- Nephronophthisis 4
- Senior-Loken syndrome 4
- NPHP4-related disorder
- Retinal dystrophy
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.98
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.24
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin cytoskeleton organization
- cell-cell adhesion
- flagellated sperm motility
- negative regulation of canonical Wnt signaling pathway
- photoreceptor cell maintenance
- photoreceptor cell outer segment organization
- positive regulation of bicellular tight junction assembly
- protein localization to ciliary transition zone
- retina development in camera-type eye
- signal transduction
- visual behavior
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- NPH4
- NPHP4, Ig-like domain 4
- NPHP4, Ig-like domain 3
- NPHP4, Ig-like domain 1
- NPHP4, Ig-like domain 2
- NPHP4, SK-like domain
- NPHP4, C2-like domain
- NPH4 Ig-like domain 3
- Nephrocystin-4 SK-like domain
- Nephrocystin-4 C2 third domain
- NPH4 Ig-like domain 4
- NPH4 Ig-like domain 2
- NPH4 Ig-like domain 1
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NPHP4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NPHP4 as an antibody target. Whether an autoantibody or antibody against NPHP4 could matter depends on whether native NPHP4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NPHP4 is annotated at the cell surface, where native NPHP4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label NPHP4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...